Pancreatic Enzyme Replacement and Nutritional Support With nab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic Cancer

BACKGROUND: At diagnosis, more than 80% of patients with pancreatic cancer (PC) suffer from significant weight loss due to malnutrition which is a major concern for patient management, and this may negatively impact treatment outcomes and patient prognosis. PATIENTS AND METHODS: We performed an obse...

Descripción completa

Detalles Bibliográficos
Autores principales: Giordano, Guido, Cincione, Raffaele Ivan, Losavio, Francesca, Senia, Tiziano, Aquilini Mummolo, Arianna, Pacilli, Mario, Lizzi, Vincenzo, Bruno, Giuseppina, Piscazzi, Annamaria, Conteduca, Vincenza, Landriscina, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Symptom Management and Supportive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485404/
https://www.ncbi.nlm.nih.gov/pubmed/37155993
http://dx.doi.org/10.1093/oncolo/oyad101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485404/
https://www.ncbi.nlm.nih.gov/pubmed/37155993
http://dx.doi.org/10.1093/oncolo/oyad101

Ejemplares similares